申请人:Ludwig-Maximilians-Universität München
公开号:US20150190370A1
公开(公告)日:2015-07-09
The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.